← Open Payments lookup

BRIAN PERRY: Open Payments

NPI 1992254486 · PARAGOULD, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$679 in 23 payments from 9 companies in 2025. Trend: 2023 $726 · 2024 $712 · 2025 $679

Food & beverage: $679
CompanyPaymentsAmount
Axsome Therapeutics, Inc.6$237
Otsuka America Pharmaceutical, Inc.3$122
Alkermes, Inc.4$108
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$73
E.R. Squibb & Sons, L.L.C.2$46
Neurocrine BioSciences, Inc.2$42
Janssen Pharmaceuticals, Inc1$22
Takeda Pharmaceuticals U.S.A., Inc.1$15
ABBVIE INC.1$15

Products named: Auvelity, ABILIFY MAINTENA, CAPLYTA, ARISTADA, COBENFY, INGREZZA, LYBALVI, SPRAVATO.

Industry payments across AR — which companies pay providers there.